scispace - formally typeset
Open AccessJournal ArticleDOI

The Mutational Landscape of Prostate Cancer

Reads0
Chats0
TLDR
The possibility that PCa could soon transition from being a poorly understood, heterogeneous disease with a variable clinical course to being a collection of homogenous subtypes identifiable by molecular criteria, associated with distinct risk profiles, and perhaps amenable to specific management strategies or targeted therapies is raised.
About
This article is published in European Urology.The article was published on 2013-10-01 and is currently open access. It has received 231 citations till now.

read more

Citations
More filters
Journal ArticleDOI

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.

TL;DR: Modifications to the Gleason grading system are incorporated into the 2016 WHO section on grading of prostate cancer, and it is recommended that the percentage of pattern 4 should be reported for Gleason score 7.
Journal ArticleDOI

Cancer genetics and genomics of human FOX family genes

TL;DR: Whole-genome sequencing data from tens of thousands of human cancers will uncover the mutational landscape of FOX family genes themselves as well as FOX-binding sites, which will be ultimately applied for cancer diagnostics, prognostics, and therapeutics.
Journal ArticleDOI

Androgen Signaling in Prostate Cancer

TL;DR: Current understanding of AR signaling as it pertains to the biology and natural history of prostate cancer is reviewed.
Journal ArticleDOI

Evolution of androgen receptor targeted therapy for advanced prostate cancer

TL;DR: This Review aims to revisit the discovery and evolution of androgen receptor targeting therapeutics for the treatment of advanced-stage prostate cancer over the years and to discuss the upcoming future and challenges in the Treatment of this common cancer.
References
More filters
Journal ArticleDOI

Global cancer statistics

TL;DR: A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination, and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake.
Journal ArticleDOI

Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

TL;DR: In this article, the authors used a bioinformatics approach to discover candidate oncogenic chromosomal aberrations on the basis of outlier gene expression and identified recurrent gene fusions of the 5' untranslated region of TMPRSS2 to ERG or ETV1.
Journal ArticleDOI

The polycomb group protein EZH2 is involved in progression of prostate cancer

TL;DR: Dysregulated expression of EZH2 may be involved in the progression of prostate cancer, as well as being a marker that distinguishes indolent prostate cancer from those at risk of lethal progression.
Related Papers (5)

Integrative clinical genomics of advanced prostate cancer

Dan R. Robinson, +89 more
- 21 May 2015 -